Title |
Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy
|
---|---|
Published in |
International Journal of Nanomedicine, September 2016
|
DOI | 10.2147/ijn.s104635 |
Pubmed ID | |
Authors |
Xun Jin, Bingwen Zou, Li Luo, Chuanhong Zhong, Peilan Zhang, Hao Cheng, Yanfang Guo, Maling Gou |
Abstract |
Cancer chemotherapy can benefit from the combination of different anticancer drugs. Here, we prepared doxorubicin (Dox)- and thioridazine (Thio)-coloaded methoxy poly(ethylene glycol)-poly(l-lactic acid) (MPEG-PLA) nanoparticles (NPs) for breast cancer therapy. These NPs have an average particle size of 27 nm. The drug loading efficiencies of Thio and Dox are 4.71% and 1.98%, respectively. Compared to the treatment of Thio or Dox alone, the combination of Thio and Dox exhibited a synergistic effect in inhibiting the growth of 4T1 breast cancer cells in vitro. In addition, the Thio- and Dox-coloaded MPEG-PLA NPs could efficiently suppress the growth of breast cancer cells in vivo. This study suggests that Thio- and Dox-coloaded MPEG-PLA NPs might have potential applications in breast cancer treatment. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 4 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 3 | 75% |
Members of the public | 1 | 25% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 21 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 6 | 29% |
Student > Ph. D. Student | 4 | 19% |
Researcher | 2 | 10% |
Student > Doctoral Student | 1 | 5% |
Student > Bachelor | 1 | 5% |
Other | 4 | 19% |
Unknown | 3 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 7 | 33% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 19% |
Agricultural and Biological Sciences | 2 | 10% |
Medicine and Dentistry | 2 | 10% |
Chemistry | 2 | 10% |
Other | 1 | 5% |
Unknown | 3 | 14% |